For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Sonus Pharmaceuticals, Inc.

USPTO Granted Patents = 32

% Expired Patents = 40.6

EPO Patents = 1

Forward Citations = 1,510

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Steven C Quay (19 out of 94 patents)

Manjari Lal (8 out of 8 patents)

Panayiotis P Constantinides (7 out of 24 patents)

4. Yuehua Zhang (7 out of 7 patents)

5. Karel J Lambert (7 out of 7 patents)

6. Nagesh Palepu (5 out of 5 patents)

7. Lynn Gold (4 out of 6 patents)

8. Alexander K Tustian (4 out of 5 patents)

9. Andrew Leo (2 out of 2 patents)

10. Dean R Kessler (2 out of 2 patents)

11. Andrew M Nienstedt (1 out of 1 patent)

12. Steven M Quay (1 out of 1 patent)

13. Ronald A Roy (1 out of 1 patent)

14. Dilip Worah (1 out of 1 patent)

15. Lynn C Gold (0 patent)

32 patents: Sort by Forward Citations

1. 7786164 - Lipophilic di(anticancer drug) compounds, compositions, and related methods (2010-08-31),

2. 7786134 - Lipophilic anticancer drug compounds, compositions and related methods (2010-08-31),

3. 7268245 - Multinuclear platinum compounds (2007-09-11),

4. 7232919 - Platinum compounds (2007-06-19),

5. 7223770 - Tocopherol-modified therapeutic drug compounds (2007-05-29),

6. 7129368 - Platinum carboxylate anticancer compounds (2006-10-31),

7. 7091374 - Fluorinated compounds (2006-08-15),

8. 7038071 - Platinum compounds (2006-05-02),

9. 7030155 - Emulsion vehicle for poorly soluble drugs (2006-04-18),

10. 6982282 - Emulsion vehicle for poorly soluble drugs (2006-01-03),

11. 6864386 - Fluorinated compounds (2005-03-08),

12. 6858227 - Vitamin E conjugates (2005-02-22),

13. 6727280 - Method for treating colorectal carcinoma using a taxane/tocopherol formulation (2004-04-27),

14. 6683194 - Tocopherol derivatives (2004-01-27),

15. 6667048 - Emulsion vehicle for poorly soluble drugs (2003-12-23),

Sonus Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative small molecule drugs for the treatment of cancer. With a strong emphasis on oncology, Sonus is committed to advancing novel therapies that can potentially transform the lives of cancer patients. For more information about our company and pipeline of drug candidates, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

32 Patents

#15 in Bothell, WA

#225 in Washington

#10,574 in US

#20,618 in the World

Bothell, WA, United States of America

Sonus Pharmaceuticals, Inc.

Forward Citations = 1,510

14 inventors:

Steven C Quay (19 out of 94 patents)

Manjari Lal (8 out of 8 patents)

Panayiotis P Constantinides (7 out of 24 patents)

4. Yuehua Zhang (7 out of 7 patents)

5. Karel J Lambert (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…